Evidence map›Paper›PMID 36466928›Full record

ArticleFrontiers in immunology2022

Perturbations of the T-cell immune repertoire in kidney transplant rejection.

Tara K Sigdel, Paul A Fields, Juliane Liberto, Izabella Damm, Maggie Kerwin, Jill Hood, Parhom Towfighi, Marina Sirota, Harlan S Robins, Minnie M Sarwal

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tara K SigdelDepartment of Surgery, Division of Multi Organ Transplantation, University of California, San Francisco, San Francisco, CA, United States.
Paul A FieldsAdaptive Biotechnologies, Seattle, WA, United States.
Juliane LibertoDepartment of Surgery, Division of Multi Organ Transplantation, University of California, San Francisco, San Francisco, CA, United States.
Izabella DammDepartment of Surgery, Division of Multi Organ Transplantation, University of California, San Francisco, San Francisco, CA, United States.
Maggie KerwinDepartment of Surgery, Division of Multi Organ Transplantation, University of California, San Francisco, San Francisco, CA, United States.
Jill HoodAdaptive Biotechnologies, Seattle, WA, United States.
Parhom TowfighiDepartment of Surgery, Division of Multi Organ Transplantation, University of California, San Francisco, San Francisco, CA, United States.
Marina SirotaDepartment of Surgery, Division of Multi Organ Transplantation, University of California, San Francisco, San Francisco, CA, United States.
Harlan S RobinsAdaptive Biotechnologies, Seattle, WA, United States.
Minnie M SarwalDepartment of Surgery, Division of Multi Organ Transplantation, University of California, San Francisco, San Francisco, CA, United States.
University of California, San Francisco · USAdaptive Biotechnologies (United States) · US

Funding

Project 3: Mapping the Evolution of Chronic Transplant Injury in the Context of CMV InfectionU19AI128913 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REED, ELAINE F, SARWAL, MINNIE M · 2017 to 2021
$11.2M
NIAID NIH HHS U19 AI128913
6 · The paper itself

Abstract

In this cross-sectional and longitudinal analysis of mapping the T-cell repertoire in kidney transplant recipients, we have investigated and validated T-cell clonality, immune repertoire chronology at rejection, and contemporaneous allograft biopsy quantitative tissue injury, to better understand the pathobiology of acute T-cell fraction, T-cell repertoire and antibody-mediated kidney transplant rejection. To follow the dynamic evolution of T-cell repertoire changes before and after engraftment and during biopsy-confirmed acute rejection, we sequenced 323 peripheral blood samples from 200 unique kidney transplant recipients, with (n=100) and without (n=100) biopsy-confirmed acute rejection. We report that patients who develop acute allograft rejection, have lower (p=0.01) T-cell fraction even before transplantation, followed by its rise after transplantation and at the time of acute rejection accompanied by high TCR repertoire turnover (p=0.004). Acute rejection episodes occurring after the first 6 months post-transplantation, and those with a component of antibody-mediated rejection, had the highest turnover; p=0.0016) of their T-cell repertoire. In conclusion, we validated that detecting repertoire changes in kidney transplantation correlates with post-transplant rejection episodes suggesting that T-cell receptor sequencing may provide recipient pre-transplant and post-transplant predictors of rejection risk.

Indexed as

Kidney TransplantationT-LymphocytesAntibodiesBiopsyCross-Sectional StudiesHumansPostoperative ComplicationsAntibodiesacute rejectionantibody-mediated rejectionimmune repertoirekidney transplantationT cell-mediated rejectionTCR sequencing

Identifiers

PMID36466928
PMCPMC9709472
OpenAlexW4309310512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.